Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - CRISPR Therapeutics AG (CRSP)
Select Time period:

Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...

Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
CRSP Insider Trading Transactions for CRISPR Therapeutics AG
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
Date
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-08-31
Sale
2017-09-05
6:33 pm
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
18,470 $20.76 $383,393 1,151,860
(Direct)
View
2017-08-28
Sale
2017-08-30
6:36 pm
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
75,795 $20.25 $1,534,869 1,232,697
(Direct)
View
2017-08-28
Sale
2017-08-30
6:12 pm
CRISPR Therapeutics AG CRSP Kulkarni Samarth
Chief Business Officer
27,154 $20.08 $545,162 110,893
(Direct)
View
2017-08-28
Sale
2017-08-30
4:18 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
88,011 $19.79 $1,741,738 1,951,359
(Indirect)
View
2017-08-24
Sale
2017-08-28
4:33 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
22,781 $19.42 $442,403 2,054,283
(Indirect)
View
2017-08-22
Sale
2017-08-24
4:02 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
17,989 $18.53 $333,336 2,069,186
(Indirect)
View
2017-08-18
Sale
2017-08-22
4:02 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
3,150 $18.52 $58,345 2,081,390
(Indirect)
View
2017-08-16
Sale
2017-08-18
4:16 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
34,141 $19.06 $650,693 2,096,883
(Indirect)
View
2017-08-14
Sale
2017-08-16
4:14 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
55,569 $19.59 $1,088,561 2,143,017
(Indirect)
View
2017-08-07
Sale
2017-08-09
4:12 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
35,473 $18.63 $660,888 2,210,722
(Indirect)
View
2017-08-04
Sale
2017-08-08
5:52 pm
CRISPR Therapeutics AG CRSP Dylan-Hyde Tyler
Chief Legal Officer
15,000 $18.57 $278,479 167,727
(Direct)
View
2017-08-03
Sale
2017-08-07
4:18 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
50,477 $17.81 $899,216 2,229,413
(Indirect)
View
2017-07-31
Sale
2017-08-02
4:21 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
5,512 $17.51 $96,491 2,277,086
(Indirect)
View
2017-07-27
Sale
2017-07-31
4:07 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
41,312 $17.63 $728,134 2,282,734
(Indirect)
View
2017-07-25
Sale
2017-07-27
4:51 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
32,930 $17.6 $579,545 2,347,390
(Indirect)
View
2017-07-13
Sale
2017-07-17
4:11 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
69,859 $16.84 $1,176,710 2,392,806
(Indirect)
View
2017-07-11
Sale
2017-07-13
4:00 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
31,992 $16.56 $529,938 2,426,435
(Indirect)
View
2017-07-05
Sale
2017-07-07
4:24 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
4,254 $16.26 $69,170 2,440,555
(Indirect)
View
2017-06-28
Sale
2017-06-30
4:50 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
43,202 $16.9 $730,125 2,456,419
(Indirect)
View
2017-06-26
Sale
2017-06-28
4:05 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
81,435 $17.08 $1,390,611 2,521,445
(Indirect)
View
2017-06-22
Sale
2017-06-26
4:39 pm
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
32,368 $16.23 $525,302 2,600,287
(Indirect)
View
2017-06-22
Sale
2017-06-23
4:20 pm
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
10,825 $15.37 $166,388 1,225,830
(Direct)
View
2017-06-19
Sale
2017-06-21
5:42 pm
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
30,222 $15.01 $453,511 1,266,583
(Direct)
View
2017-06-08
Sale
2017-06-12
5:02 pm
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
5,303 $15.02 $79,628 1,219,208
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
Date
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-11-13
Option Award
2017-11-14
5:19 pm
N/A
2027-11-21
CRISPR Therapeutics AG CRSP TOMSICEK MICHAEL JOHN
Chief Financial Officer
180,000 $17.75 180,000
(Direct)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
1,368,013 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
8,110 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
814,599 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
23,899 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
61,993 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
26,491 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
292,529 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
292,529 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
17,283 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
17,283 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
1,240 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:35 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
1,240 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,368,013 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
8,110 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
814,599 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
23,899 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
61,993 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
26,491 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
292,529 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
292,529 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
17,283 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
17,283 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,240 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,240 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
9,918 $0 2,736,032
(Direct)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
1,368,013 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
8,110 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
814,599 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
23,899 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
61,993 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
26,491 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
292,529 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
292,529 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
17,283 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
17,283 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
1,240 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
1,240 $0 2,736,032
(Indirect)
View
2017-09-05
Other
2017-09-07
9:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
55,447 $0 2,736,032
(Direct)
View
2017-08-31
Exercise
2017-09-05
6:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
3,853 $1.81 1,151,860
(Direct)
View
2017-08-31
Exercise
2017-09-05
6:33 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
3,853 $1.81 1,151,860
(Direct)
View
2017-08-28
Exercise
2017-08-30
6:36 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
17,692 $1.81 1,232,697
(Direct)
View
2017-08-28
Exercise
2017-08-30
6:36 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
5,722 $1.81 1,232,697
(Direct)
View
2017-08-28
Exercise
2017-08-30
6:36 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
17,692 $1.81 1,232,697
(Direct)
View
2017-08-28
Exercise
2017-08-30
6:36 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
5,722 $1.81 1,232,697
(Direct)
View
2017-08-01
Option Award
2017-08-02
4:30 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Ho Tony W
See Remarks
75,000 $0 260,000
(Direct)
View
2017-08-01
Option Award
2017-08-02
4:30 pm
N/A
2027-08-01
CRISPR Therapeutics AG CRSP Ho Tony W
See Remarks
260,000 $16.9 260,000
(Direct)
View
2017-06-22
Exercise
2017-06-23
4:20 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
10,825 $1.81 1,225,830
(Direct)
View
2017-06-22
Exercise
2017-06-23
4:20 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
10,825 $1.81 1,225,830
(Direct)
View
2017-06-19
Exercise
2017-06-21
5:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
15,392 $1.81 1,266,583
(Direct)
View
2017-06-19
Exercise
2017-06-21
5:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
3,252 $1.81 1,266,583
(Direct)
View
2017-06-19
Exercise
2017-06-21
5:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
11,578 $1.81 1,266,583
(Direct)
View
2017-06-19
Exercise
2017-06-21
5:42 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
15,392 $1.81 1,266,583
(Direct)
View
2017-06-19
Exercise
2017-06-21
5:42 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
3,252 $1.81 1,266,583
(Direct)
View
2017-06-19
Exercise
2017-06-21
5:42 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
11,578 $1.81 1,266,583
(Direct)
View
2017-06-15
Option Award
2017-06-19
4:05 pm
N/A
2027-06-15
CRISPR Therapeutics AG CRSP Dylan-Hyde Tyler
Chief Legal Officer
65,000 $14.43 65,000
(Direct)
View
2017-06-15
Option Award
2017-06-19
4:05 pm
N/A
2027-06-15
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
270,000 $14.43 270,000
(Direct)
View
2017-06-15
Option Award
2017-06-19
4:05 pm
N/A
2027-06-15
CRISPR Therapeutics AG CRSP Subramanian Kala
See Remarks
85,000 $14.43 85,000
(Direct)
View
2017-06-08
Exercise
2017-06-12
5:02 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
4,203 $1.81 1,219,208
(Direct)
View
2017-06-08
Exercise
2017-06-12
5:02 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
1,100 $1.81 1,219,208
(Direct)
View
2017-06-08
Exercise
2017-06-12
5:02 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
4,203 $1.81 1,219,208
(Direct)
View
2017-06-08
Exercise
2017-06-12
5:02 pm
N/A
2025-09-10
CRISPR Therapeutics AG CRSP Novak Rodger
Chief Executive Officer
Director
1,100 $1.81 1,219,208
(Direct)
View
2017-05-31
Option Award
2017-06-02
4:37 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP George Simeon
Director
15,000 $13.62 15,000
(Direct)
View
2017-05-31
Option Award
2017-06-02
4:33 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP Behbahani Ali
Director
15,000 $13.62 15,000
(Direct)
View
2017-05-31
Option Award
2017-06-02
4:31 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP EMSTER KURT VON
Director
15,000 $13.62 15,000
(Direct)
View
2017-05-31
Option Award
2017-06-02
4:30 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP CAGNONI PABLO J
Director
15,000 $13.62 15,000
(Direct)
View
2017-05-31
Option Award
2017-06-02
4:30 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,000 $13.62 30,000
(Indirect)
View
2017-05-31
Option Award
2017-06-02
4:30 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP Bolzon Bradley J PhD
Director
30,000 $13.62 30,000
(Indirect)
View
2017-05-31
Option Award
2017-06-02
4:30 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP KASINGER JAMES R.
General Counsel and Secretary
123,000 $13.62 123,000
(Direct)
View
Goto page 0, 1, Next